ArticleInfectious diseases of poverty2020
Strategies supporting the prevention and control of neglected tropical diseases during and beyond the COVID-19 pandemic.
Article in Infectious diseases of poverty, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 58 citations in OpenAlex.
- Understanding the Feasibility to Implement Schistosomiasis Elimination Project Under China-Zimbabwe Cooperation: A Pilot Study Protocol.Journal of epidemiology and global health · 2025Article
- Mortality due to schistosomiasis in an endemic area of Brazil: a population-based ecological study.BMC infectious diseases · 2025Article
- Comparative Analysis of Intestinal Parasitic Infections and Risk Factors Affected by the Pandemic Among Primary Schoolchildren in the Provinces of Manzini and Lubombo, Kingdom of Eswatini: A Follow-Up Study in 2019 and 2022.Journal of tropical medicine · 2025Article
- The Changing Face of Helminth Infections: A 15-Year Temporal Analysis from Eastern Saudi Arabia.Infection and drug resistance · 2025Article
- Innovating Leishmaniasis Treatment: A Critical Chemist's Review of Inorganic Nanomaterials.ACS infectious diseases · 2024Review
- Understanding how neglected tropical diseases programs in five Asia-Pacific countries adjusted to the COVID-19 pandemic: A qualitative study.PLoS neglected tropical diseases · 2024Article
- Knowledge, Attitudes, and Practices Regarding Tropical Diseases among Nursing Students: A Comparative Cross-Sectional Study.The American journal of tropical medicine and hygiene · 2024Article
- Assessing the impact of the COVID-19 pandemic on neglected tropical diseases in India: a perspective.Frontiers in public health · 2024Review
- Impact of the COVID-19 Pandemic on Pharmacist Interventions: A Retrospective Study with Inpatients in a University Hospital.The Canadian journal of hospital pharmacy · 2024Article
- Emerging zoonotic diseases and COVID-19 pandemic: global Perspective and Indian Scenario.Annals of medicine and surgery (2012) · 2023Article
- Temporal patterns, spatial risks, and characteristics of tegumentary leishmaniasis in Brazil in the first twenty years of the 21st Century.PLoS neglected tropical diseases · 2023Article
- COVID-19 and neglected tropical diseases among refugees: Plight of a vulnerable population in Africa.Public health challenges · 2023Article
- Evaluating and mitigating the potential indirect effect of COVID-19 on control programmes for seven neglected tropical diseases: a modelling study.The Lancet. Global health · 2022Article
- Leishmaniasis control in the light of the COVID-19 pandemic in Africa.Annals of medicine and surgery (2012) · 2022Article
- Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: a spatiotemporal modelling study.The Lancet. Infectious diseases · 2022Article
- Revisiting nature: a review of iridoids as a potential antileishmanial class.Phytochemistry reviews : proceedings of the Phytochemical Society of Europe · 2022Review
- Safely resuming neglected tropical disease control activities during COVID-19: Perspectives from Nigeria and Guinea.PLoS neglected tropical diseases · 2021Article
- Impact of interventions on the incidence of natural focal diseases during the outbreak of COVID-19 in Jiangsu Province, China.Parasites & vectors · 2021Article
- Coinfection of disseminated cryptococcosis and BK Virus, a casualty of missed diagnosis during the COVID-19 Pandemic: A case report and review of the literature.Current medical mycology · 2021Article
- Optimization of DNA Extraction from Field-Collected Mammalian Whole Blood on Filter Paper forPathogens (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 5 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emerging and re-emerging zoonotic diseases represent a public health challenge of international concern. They include a large group of neglected tropical diseases (NTDs), many of which are of zoonotic nature. Coronavirus disease 2019 (COVID-19), another emerging zoonotic disease, has just increased the stakes exponentially. Most NTDs are subject to the impact of some of the very same human-related activities triggering other emerging and re-emerging diseases, including COVID-19, severe acute respiratory syndrome (SARS), bird flu and swine flu. It is conceivable that COVID-19 will exacerbate the NTDs, as it will divert much needed financial and human resources. There is considerable concern that recent progress achieved with control and elimination efforts will be reverted. Future potential strategies will need to reconsider the determinants of health in NTDs in order to galvanize efforts and come up with a comprehensive, well defined programme that will set the stage for an effective multi-sectorial approach. In this Commentary, we propose areas of potential synergies between the COVID-19 pandemic control efforts, other health and non-health sector initiatives and NTD control and elimination programmes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.